|
|
Prepublished online as a Blood First Edition Paper on October 31, 2002; DOI 10.1182/blood-2002-02-0456.

Submitted February 12, 2002
Accepted September 17, 2002
Constitutive exclusion of Csk from Hck-positive membrane microdomains permits Src kinase-dependent proliferation of Theileria-transformed B-lymphocytes
Martin Baumgartner, Pavla Angelisova, Niclas Setterblad, Nuala Mooney, Dirk Werling, Vaclav Horejsi, and Gordon Langsley*
Department of Parasitology, Institut Pasteur, Paris, France, France
Institute of Moleuclar Genetics, Prague, Czech Republic
Immunogenetic Humaine, INSERM, Unite 396, Paris, France
Faculty of Veterinary Medicine, Institute of Veterinary Virology, Bern, Switzerland
Department of Stomatology, University of California, San Francisco, San Francisco, CA, USA
* Corresponding author; email: langsley{at}pasteur.fr.
Infection of bovine T cells and B cells with the intracellular protozoan parasite Theileria parva induces a transformed phenotype with characteristics comparable to leukaemic cells. The transformed phenotype reverts upon drug-induced parasite death and the cured lymphocytes acquire a resting phenotype and eventually die by apoptosis if not further stimulated. Here, we show that both lymphocyte proliferation and activation of the transcription factor AP-1 are mediated by Src-family protein tyrosine kinases (PTKs) in a parasite-dependent fashion. Src-family PTKs are known to be present in glycolipid-enriched microdomains (GEMs), also called lipid rafts, and to be negatively regulated by PTK Csk complexed to tyrosine-phosphorylated transmembrane adapter protein PAG (phosphoprotein associated with GEMs) called also Cbp (Csk-binding protein). We therefore purified GEMs from proliferating infected B cells and from growth-arrested cells that had been drug-cured of parasites. Proliferation arrest led to a striking increase of PAG/Cbp expression; correspondingly, the amount of Csk associated with PAG/Cbp in GEMs increased markedly whereas PTK Hck accumulation in GEM fractions did not alter upon growth arrest. We propose that Theileria-induced lymphocyte proliferation and permanent activation of Hck stems from down-regulation of PAG/Cbp and the concomitant constitutive loss of the negative regulator Csk from the GEMs of transformed B cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Tauzin, H. Ding, K. Khatib, I. Ahmad, D. Burdevet, G. van Echten-Deckert, J. A. Lindquist, B. Schraven, N.-u. Din, B. Borisch, et al.
Oncogenic association of the Cbp/PAG adaptor protein with the Lyn tyrosine kinase in human B-NHL rafts
Blood,
February 15, 2008;
111(4):
2310 - 2320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Lizundia, M. Chaussepied, M. Huerre, D. Werling, J. P. Di Santo, and G. Langsley
c-Jun NH2-Terminal Kinase/c-Jun Signaling Promotes Survival and Metastasis of B Lymphocytes Transformed by Theileria.
Cancer Res.,
June 15, 2006;
66(12):
6105 - 6110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Zhu, B. Y. Choi, W.-Y. Ma, Z. Zhao, Y. Zhang, Y. Y. Cho, H. S. Choi, A. Imamoto, A. M. Bode, and Z. Dong
COOH-Terminal Src Kinase-Mediated c-Jun Phosphorylation Promotes c-Jun Degradation and Inhibits Cell Transformation
Cancer Res.,
June 1, 2006;
66(11):
5729 - 5736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Munter, M. Way, and F. Frischknecht
Signaling During Pathogen Infection
Sci. Signal.,
May 16, 2006;
2006(335):
re5 - re5.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tedoldi, J. C. Paterson, M.-L. Hansmann, Y. Natkunam, T. Rudiger, P. Angelisova, M. Q. Du, H. Roberton, G. Roncador, L. Sanchez, et al.
Transmembrane adaptor molecules: a new category of lymphoid-cell markers
Blood,
January 1, 2006;
107(1):
213 - 221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Brdickova, T. Brdicka, P. Angelisova, O. Horvath, J. Spicka, I. Hilgert, J. Paces, L. Simeoni, S. Kliche, C. Merten, et al.
LIME: A New Membrane Raft-associated Adaptor Protein Involved in CD4 and CD8 Coreceptor Signaling
J. Exp. Med.,
November 17, 2003;
198(10):
1453 - 1462.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |